Silo Pharma, Inc. (SILO) Institutional Ownership

Ownership Summary

Silo Pharma, Inc. (NASDAQ:SILO) showed up in the 13F filings of 15 institutional investors as of December 2025.

• These investors held 13.0% of outstanding shares in December 2025, down from 16.6% in September 2025.
• They increased total shares held in Silo Pharma by 113.36% from last quarter, and the number of investors in SILO decreased 6.25% annually.
• Among the 15 funds, 8 bought more Silo Pharma shares, 4 sold down, and 3 held their ground.
• Combined, these investors held 1.21Mn shares in SILO for December 2025, up by 644.82K shares quarter on quarter, and up 1.03Mn shares year over year.
• As of December 31, 2025, AdvisorShares Investments LLC held the largest stake in Silo Pharma with 599.51K shares, accounting for 6.42% of total shares outstanding.
• Top purchasers of SILO stock for the quarter ending December 2025 included DRW Securities, LLC (333.73K), AdvisorShares Investments LLC (234.63K), XTX Topco Ltd (56.9K), GEODE CAPITAL MANAGEMENT, LLC (53.31K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.58K).
• Top sellers of SILO stock for the quarter ending December 2025 included Virtu Financial LLC (89.37K), UBS Group AG (2.94K), Bank Of America Corp /De/ (44), Tower Research Capital LLC (TRC) (12).
• According to Business Quant data, leading holders of SILO for December 2025 are AdvisorShares Investments LLC (599.51K), DRW Securities, LLC (333.73K), GEODE CAPITAL MANAGEMENT, LLC (92.9K), XTX Topco Ltd (56.9K), JANE STREET GROUP, LLC (34.37K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.58K), VANGUARD GROUP INC (24.32K), Virtu Financial LLC (18.42K), State Street Corp (12.5K), UBS Group AG (6.04K).